Resistance factors in colon cancer tissue and the adjacent normal colon tissue: glutathione S-transferases α and π, glutathione and aldehyde dehydrogenase

Glutathione S-transferases (GST) α and π, glutathione (GSH) and aldehyde dehydrogenase (ADH) were determined in colorectal cancer tissue specimens and in the adjacent normal colon tissue. The median contents in normal and cancer tissue were 8.1 (2.3–30.3) (5–95% quantiles) and 15.1 (5.3–50.3) μg/mg protein for GST π (P=0.035), 0.0 (0.0–1.4) and 0.4 (0.0–3.5) μg/mg protein for GST α (P=0.019), 7.3 (1.3–22.7) and 5.6 (2.3–26.0) μg/mg protein for GSH (P=0.171) and 30.8 (13.0–42.0) and 23.2 (9.0–32.9) μg/mg protein for ADH (P=0.0017), respectively. Thus, the mean GST α and π both significantly increased in colon cancer compared to the adjacent normal tissue, which underlines their importance as possible resistance factors. A highly significant correlation was obtained between the GSH content in colon cancer and normal tissue (P=0.0017). Thus, the constitutive GSH expression seems to be maintained during tumor development. A similar correlation was obtained for ADH (P=0.0075), but the median ADH was lower in cancer tissue compared to the adjacent normal tissue (P=0.0017). Contrary to GSH and ADH, GST π did not correlate between normal and colon cancer tissue. Whereas GSH and ADH correlated in normal colon tissue (P=0.014), no significant correlation for GSH and ADH was observed in colon cancer tissue (P=0.109). In conclusion, significant correlations between colon cancer and normal tissue were obtained, suggesting that the expression levels of these resistance factors are maintained during carcinogenesis in most patients.